EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C25H35BN4O8 |
| Net Charge | 0 |
| Average Mass | 530.387 |
| Monoisotopic Mass | 530.25479 |
| SMILES | [H][C@]1([C@H](O)CO)OB([C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)c2cnccn2)O[C@]1([H])[C@H](O)CO |
| InChI | InChI=1S/C25H35BN4O8/c1-15(2)10-21(26-37-22(19(33)13-31)23(38-26)20(34)14-32)30-24(35)17(11-16-6-4-3-5-7-16)29-25(36)18-12-27-8-9-28-18/h3-9,12,15,17,19-23,31-34H,10-11,13-14H2,1-2H3,(H,29,36)(H,30,35)/t17-,19+,20+,21-,22+,23+/m0/s1 |
| InChIKey | QDMRNLRJDHCHLB-DNNBANOASA-N |
| Roles Classification |
|---|
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| bortezomib d-mannitol (CHEBI:759801) has role antineoplastic agent (CHEBI:35610) |
| bortezomib d-mannitol (CHEBI:759801) is a phenylalanine derivative (CHEBI:25985) |
| Synonyms | Source |
|---|---|
| Bortezomib d-mannitol | ChEMBL |
| Bortezomib d-mannitol ester | ChEMBL |
| Bortezomib mannitol boronic ester | ChEMBL |
| Brand Names | Source |
|---|---|
| Bortezomib accord | ChEMBL |
| Bortezomib fresenius kabi | ChEMBL |
| Bortezomib hospira | ChEMBL |
| Bortezomib sun | ChEMBL |